Pharmacotherapy of Obesity

1. Why drugs?
F. Xavier Pi-Sunyer

2. Some historical aspects of drug treatment for obesity
George A. Bray

3. Regulation of energy balance — towards rational drug design in obesity
Joanne A. Harrold, John P. H. Wilding

4. Intestinal lipase inhibitors
John P. H. Wilding

5. Sibutramine
John P. H. Wilding

6. The endocannabinoid system as a target for obesity treatment
Muhammad Khan, John P. H. Wilding

7. Using the body’s natural signals — gut hormones
Owais B. Chaudhri, Kirsty L. Smith, Stephen R. Bloom

8. Influencing energy expenditure and substrate utilisation
John C. Clapham, Jonathan R. Arch

DRM-restrictions

Printing: not available
Clipboard copying: not available

Avainsanat: TECHNOLOGY & ENGINEERING / Biomedical TEC059000